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   lthough the prevalence of caries has decreased dramatically over the past decades, it has become a polarised disease,
with most of subjects presenting low caries levels and few individuals accounting for most of the caries affected surfaces.
Thus it become evident for the need of clinical approaches directed at these high-risk patients, in order to overcome problems
related to compliance and low attendance at dental care centres. Slow-release fluoride devices were developed based on the
inverse relationship existing between intra-oral fluoride levels and dental caries experience. The two main types of slow-release
devices – copolymer membrane type and glass bead – are addressed in the present review. A substantial number of studies
have demonstrated that these devices are effective in raising intra-oral F concentrations at levels able to reduce enamel
solubility, resulting in a caries-protective effect. Studies in animals and humans demonstrated that the use of these devices was
able to also protect the occlusal surfaces, not normally protected by conventional fluoride regimens. However, retention rates
have been shown to be the main problem related to these devices and still requires further improvements. Although the results
of these studies are very promising, further randomised clinical trials are needed in order to validate the use of these devices
in clinical practice.  The concept of continuously providing low levels of intra-oral fluoride has great potential for caries
prevention in high caries-risk groups.
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INTRODUCTION
Dental caries is caused by acids produced by bacteria in
dental biofilms, which slowly but progressively demineralise
the enamel. Among various caries-preventive strategies,
which include education in oral health, chemical and
mechanical control of dental biofilms, the use of fluorides
has proved to be the most clinically effective according to a
large number of clinical trials, literature reviews and more
recently meta-analyses demonstrating the ability of F in
controlling dental caries in studies involving the use of
rinses, gels, varnishes and dentifrices29-32. The ability of
fluoride to retard or prevent the development of dental caries
appears to involve several mechanisms including a reduction
in the acid solubility of enamel, the promotion of enamel
remineralisation, inhibition of glucose uptake and utilization
by acidogenic bacteria, and possibly bacteriostatic or
bactericidal effects21,24.
Although the increase and the subsequent decline of
caries from the 1950’s to the early 1990’s is common in all
economically developed countries, at the same time that
dental caries prevalence has diminished it has become
strongly polarised, showing a bimodal distribution39,44. Data
from western countries showed that around 80% of all
affected surfaces corresponded to only 25% children and
adolescents23,41,44, implying that the majority of children have
no or very little caries to be treated. On the other hand, there
is still a fraction of the population in which the conventional
fluoride regimens seems to have little or no impact on caries
prevalence. In countries in which caries is known to be
polarised, there has been a promotion of high-risk strategies,
instead of the conventional population-based prevention
systems, in an attempt to overcome this problem.  However,
the effect of such a change remains questionable44. The
main problem is that regardless of what is performed all
prevention methods targeted at high caries-risk groups
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eventually fail due to the lack of patient compliance. For
countries where it is not possible to promote such high-risk
strategies, the picture becomes even worse.
 As the current scientific consensus regards a constant
supply of low levels of fluoride, especially at the biofilm/
saliva/dental interface, as being of the most benefit in
preventing dental caries18,49, it is reasonable to expect a
positive effect on caries prevalence of a treatment able to
raise intra-oral F concentrations at constant rates, without
relying on patient compliance. This concept is reinforced
by the findings of Shields, et al.47 (1987), who showed that
irrespective of water fluoridation status, caries-free children
had salivary F levels of 0.04 ppm or more whereas those
with carious dentitions had 0.02 ppm or less. Other
investigators also found salivary F levels of caries-free
individuals are higher than those found for caries-active
subjects, regardless the exposure to fluoridated drinking
water20,43,54. Generally, baseline F levels in saliva are known
to be around 0.02 ppm or less, dependent on the F level in
drinking water and the use of F products27 and are regarded
as adequate for low or medium caries challenge individuals,
but not for high caries challenge19.
Considering that intra-oral levels of F play a key role in
the dynamics of dental caries, it has been suggested that
the use of controlled and sustained delivery systems – similar
to the ones used for birth control, treatment of glaucoma
and prevention of motion sickness – can be considered as a
means of controlling dental caries incidence in high-risk
individuals35. Thereafter, a topical system of slow and
constant F release started to be investigated in in vitro, in
situ and in vivo studies.
TYPES OF DEVICES
The literature describes mainly two types of slow-release
F devices: the copolymer membrane type, developed in the
United States, and the glass bead, developed in the United
Kingdom. More recently, a third type was described, which
consists in a mixture of sodium fluoride (NaF) and
hydroxyapatite.
Copolymer membrane device
This type of slow-release fluoride device was developed
by Cowsar, et al. 15 (1976), consisting of a small pellet which
could be attached on or near the tooth surface. This system
was designed as a membrane-controlled reservoir-type and
has an inner core of hydroxyethyl methacrylate (HEMA)/
methyl methacrylate (MMA) copolymer (50:50 mixture),
containing a precise amount of sodium fluoride (NaF). This
core is surrounded by a 30:70 HEMA/MMA copolymer
membrane which controls the rate of fluoride release from
the device35. When the matrix becomes hydrated, small
quantities of granulated NaF are diluted until the matrix itself
becomes saturated. The precise water absorption rates by
the inner and the outer cores enables the devices to act
accurately and reliably as a release controlling mechanism33.
According to Marini, et al.33 (2000), hydration of the device
leads to fluoride release as indicated by Fick’s first law38: as
the saturation of NaF is 3.3 x 10-4 g/cm3 and 1.32 x 10-4 g/cm3,
respectively for the inner core and the outer membrane, F
moves spontaneously from the matrix through the membrane
and into saliva.
The device is approximately 8 mm in length, 3 mm in
width, and 2 mm in thickness36,37 as shown in Figure 1, and
is usually attached to the buccal surface of the first permanent
molar by means of stainless steel retainers that are spot
welded to plain, standard orthodontic bands7 or are bonded
to the tooth surfaces using adhesive resins37.
Depending on the amount of F in the inner core, the rate
of F release of these devices can be between 0.02 and 1.0 mg
F/day for up to 180 days. Salivary F levels were
demonstrated to remain significantly elevated throughout a
100-day test period9,12,36,37.
Glass device
Historically, the glass device was used in animal
husbandry to combat pasture and feed deficiencies of
various trace elements, such as selenium, copper and
cobalt16. Due to the association of a number of trace elements
with caries inhibition, a variant of this device was developed
in Leeds, United Kingdom, for use in dentistry in order to
assess its potential use in dental caries control53. The F
glass device dissolves slowly when moist in saliva, releasing
F without significantly affecting the device’s integrity.
The original device was dome shape, with a diameter of
4 mm and about 2 mm thick53-55, being usually attached to
the buccal surface of the first permanent molar using
adhesive resins, as shown in Figure 2. Due to the low
retention rates of the original device, it was further
substantially changed to a kidney-shaped device, being 6
mm long, 2.5 mm in width and 2.3 mm in depth (Figure 3), and
it was proven to be effective regarding both F release and
retention rate7. A new modification was introduced more
recently, in order to facilitate device handling, attachment
and replacement. This new device has been shaped in the
form of a disk that is placed within a plastic bracket (Figure
4), so a new device can be easily installed without the need
for de-bonding, removing remnants of composite resin and
performing a new acid etch and bonding the device (Figure
5)
Preliminary studies were conducted to evaluate the best
F concentration to be used in the glass devices, with F
concentrations ranging from 13.3% to 21.9%16. It was found
that devices containing 13.3% F showed a higher rate of F
release compared to devices containing higher F
concentrations (18.3% and 21.9%); this was explained by
the presence of aluminium in the high F concentration
devices, which binds to F thus reducing its release rate.
Also the glasses had different solubility rates.   In contrast
to the copolymer membrane device, the glass type has
shown a longer life time, releasing F continuous for up to 2
years43.
Hydroxyapatite-Eudragit RS100 diffusion
controlled F system
This is the newest type of slow-release F device,
which consists of a mixture of hydroxyapatite, NaF and
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FIGURE 1- Schematic cross-sectional view of the copolymer device, which originally had 8 mm in length, 3 mm in width, and
2 mm in tickness. Modified from Mirth, et al. (1982)
FIGURE 2- Original glass device attached to the buccal
surface of the first upper right permanent molar
FIGURE 3- Kidney-shaped device bonded to the upper first
permanent molar tooth
FIGURE 4- The latest version of the fluoride glass slow-
release device and plastic retention bracket
FIGURE 5- Latest glass device and bracket attached to upper
first permanent molar tooth
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Study (year)
Lewis, et al.28 (1977)
Adderly, et al.3 (1981)
Mirth, et al.36 (1983)
Shern, et al.46 (1987)
Model
Rats
Primates
Rats
Primates
Duration
Months
1 month
1 month
1 month
Finding
Controlled  F release
Elevated salivary F
Elevated salivary F
Elevated salivary F
TABLE 1- Reported salivary fluoride levels released by copolymer devices in animal studies
From: Al-Ibrahim NI. Unilateral versus bilateral placement of slow-release fluoride glass device. II. In vitro assessment of
slow-release fluoride glass device [thesis]. Leeds(UK): University of Leeds; 2007.
Eudragit RS100; it contains 18 mg of NaF and is intended to
release 0.15 mg F/day. It was demonstrated that the use of
this device is able to significantly increase salivary and
urinary F concentrations for at least 1 month6. However, as
there is only one single report in the literature on this device,
it will not be further addressed in the present review.
EFFECT ON INTRA-ORAL FLUORIDE
CONCENTRATIONS
Several in vitro and in vivo studies were conducted in
order to evaluate the resulting F levels in saliva and dental
plaque, which are the sites where the F ion can exert its
cariostatic effect during the cariogenic challenge. The results
of studies involving the immersion of copolymer devices
both in human and artificial saliva suggested an interaction
between F released by the devices and calcium from saliva1,
and that F release is directly proportional to the concentration
of calcium present in saliva2. These laboratory results,
however, were not consistent with those obtained in a further
clinical trial. After 1 month of placement of a glass device,
salivary calcium levels were not significantly different from
baseline values22.
Animal studies also found significant increases in
salivary F levels associated to the use of a copolymer
device3,28,36,46, as presented in Table 1. Such increases were
further verified in studies involving human subjects, for
periods ranging from 270 minutes35 to 2 years52 (Tables 2
and 3). As can be observed in Table 3, mean salivary F
levels associated to the copolymer membrane device spread
a wider range when compared to the glass type.
Significant increases were also found in plaque F
concentrations, both for the copolymer membrane and glass
devices. In a double-blind crossover study, it was
demonstrated that the glass device significantly elevated F
levels in plaque (~ ten fold) after 1 month of placement of
the bead22. Similar findings were obtained in a study
employing the copolymer membrane device, also for a period
of one month37, as well as in another study conducted with
primates46.
EFFECT ON CARIES PREVALENCE
REDUCTION
After proving that the use of the slow-release F devices
was able to significantly increase salivary F levels for
prolonged periods of time, the next step was to evaluate the
clinical outcomes resulted from such increases. The first
studies that aimed to verify the effect of the slow-release
devices on caries prevalence were conducted using animal
models and the copolymer type. Mirth, et al.36 (1983) reported
a 63% reduction in caries development in the test group
(rats using a device releasing 0.15 mg F/day) in comparison
to the control group (no treatment) after 1 month. The most
interesting finding, however, was that the occlusal surfaces
were also protected in that study, since 40% fewer occlusal
caries lesions were found in the test group. Another study
using a similar protocol also demonstrated that the
copolymer device significantly restricted the development
of enamel caries on the sulcal-morsal surfaces in rats45.
The only study involving humans was conducted using
the glass device. It was a double-blind clinical trial that
evaluated the development of dental caries in 174 children
aged 8 years53. Children were residents in a deprived area of
Leeds, United Kingdom, and used both fluoride (test group)
and placebo devices (control group). After 2 years of
placement of the devices, it was found that the test group
developed 67% fewer new carious teeth and 76% fewer new
carious surfaces. In agreement with the findings obtained
by Mirth, et al.36 (1983), there were 55% fewer new occlusal
fissures carious cavities, showing that the constant supply
of low doses of F is able to protect not only approximal and
free surfaces, but also those not normally protected by
traditional fluoride regimens. However, as retention rates
(discussed in a specific topic on the present review) were
low, the results were analyzed on the basis of bead retention
rather than an intention-to-treat, which led recent reviews
to conclude that the evidence from this study was not
strong10,40. Thus, although the results from this study
provide some evidence on the clinical effectiveness of glass
devices on caries control, further investigations on the topic
are still necessary.
Studies using in situ models also found positive results
on F uptake and remineralisation of enamel slabs. Corpron,
et al.12 (1986) demonstrated that enamel can be remineralised
within 7 days after the use of a copolymer membrane device,
due to the constant release of F ions into the oral
environment. The same authors suggested that the low F
levels in saliva allow the slow mineral uptake in the base of
the carious lesion, and not only on enamel surface, as
frequently occurs when high F vehicles are applied14. The
copolymer membrane device was also shown to be a similar
effect on enamel remineralisation and F uptake when
compared to a fluoridated chewing gum56. In addition, a
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dose-response relationship was verified between F
concentration released by the copolymer-type device and
enamel remineralisation11. Regarding the location of the
device, Toumba demonstrated that the glass-type device
also was able to increase surface microhardness of enamel
slabs, both in the same and the opposite sides of the mouth
Author Year Release Rate (RR)
Mirth, et al.37 1982 0.5 mg F/day
Corpron, et al.13 1991
Wang, et al.56 1993
Santos, et al.42 1994
Billings, et al.9 1998
Corpron, et al.12 1986 0.3-0.4 mg F/day
Kula, et al.26 1987 0.1± 0.02 mg F/day
Cain, et al.11 1994 0.232 ± 0.07 mg F/day
Alaçam, et al.4 1996 0.32 mg F /day
Marini, et al.34 1999 0.04 mg F/day
TABLE 2- Reported release rates of copolymer devices in clinical studies
From: Al-Ibrahim NI. I. Unilateral versus bilateral placement of slow-release fluoride glass device. II. In vitro assessment of
slow-release fluoride glass device [thesis]. Leeds(UK): University of Leeds; 2007.
Study (year) Device Type Duration F salivary level (ppm)
Cowsar, et al.15 (1976) Copolymer 30-180 days Increased
Mirth, et al.37 (1982) Copolymer 1 month 1.35
Kula, et al.26 (1987) Copolymer 26 weeks 0.645
Bashir8 (1988) Glass Up to 2 years 0.03-0.4
Cain, et al.11 (1994) Copolymer 50 days 0.18
Alaçam, et al.4 (1996) Copolymer 1 month 0.35
Billings, et al.9 (1998) Copolymer 6 months 0.69
Marini, et al.34 (1999) Copolymer 6 months 0.46
Andreadis, et al.7 (2006) Glass 6 months 0.15 (adults)
0.17 (children)
Kapetania22 (2004) Glass 1 month 0.625
Toumba and Curzon55 (2005) Glass 2 years 0.11 (0.17 at the beginning of
the study)
Altinova, et al.6 (2005) RS100 1 month Increased
Tatsi, et al.48 (2006) Glass 3 months 0.06 (F electrode)
Al-Ibrahim5 (2007) Glass 6 months 0.096-0.1
TABLE 3- Reported salivary fluoride levels released by slow release devices
From: Al-Ibrahim I. Unilateral versus bilateral placement of slow-release fluoride glass device. II. In vitro assessment of
slow-release fluoride glass device [thesis]. Leeds (UK). University of Leeds; 2007.
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dose-response relationship was verified between F
concentration released by the copolymer-type device and
enamel remineralisation11. Regarding the location of the
device, Toumba demonstrated that the glass-type device
also was able to increase surface microhardness of enamel
slabs, both in the same and the opposite sides of the mouth
from the location of the device51.
Other studies, using in situ and in vivo models, also
evaluated the potential use of slow-release devices for
reduction of orthodontic white spots, dentine sensitivity
and prevention of root caries. Marini, et al.34 (1999)
demonstrated that a copolymer device, intended to release
F for 6 months, was able to avoid the development of white
spot lesions after 1 year of using the devices by patients
under orthodontic treatment. Since randomisation
procedures were not considered as adequate by a recent
meta-analysis10, care must be taken when analysing these
results. The glass device was also proven to be effective for
such purpose. After the orthodontic treatment, the group of
subjects that used the F releasing device developed 66%
fewer white spots lesions when compared to the control
group50.
The use of a F releasing device also proved to be
effective for treating dentine sensitivity. Subjects presenting
dentine sensitivity both secondary to post-periodontal
surgery and primary sensitivity were fitted a copolymer
device for a period of 4 months33. After 4 weeks of treatment,
the symptoms decreased significantly, remaining absent
through the duration of the treatment. Regarding root caries,
in situ studies demonstrated that the use of a slow-release
F device was able to increase F uptake in root specimens
(with subsurface lesions) to a higher extent when compared
to fluoridated mouthrinses and dentifrices13 and a fluoridated
chewing gum42. Further clinical studies are still needed in
order to test and validate the efficacy of F releasing devices
for such purposes.
TOXICITY AND SIDE-EFFECTS
One of the primary concerns about the use of the slow-
release fluoride device was the possibility of de-bonding
and its subsequent ingestion, which could lead to acute
toxic effects. For this reason, since the development of the
first device (copolymer type), studies have been conducted
in order to verify the degree of safety when using these
devices in humans, especially in children.
Using an animal model, Mirth, et al.35 (1980) demonstrated
that no signs of toxicity were verified in dogs after ingestion
of devices containing 6 months supply of fluoride
(equivalent of 458 mg F). In a further clinical study, the same
research group showed no changes in F concentrations in
serum and urine of eleven human subjects after fitting
copolymer devices37. Other investigators also demonstrated
that the use of the copolymer device was able to significantly
increase salivary and plaque F concentrations without
increases in urine or serum, both in primates46 and in
humans26.
For the glass devices, a pilot study compared F levels in
blood plasma of 5 adult volunteers after ingesting either a
glass device pellet or a sodium fluoride tablet (2.2 mg NaF)
in two separate occasions16. While the ingestion of the NaF
tablet promoted the increase of plasma F concentrations
from 0.01 (baseline) to ~0.1 mg F/mL, returning to baseline
levels after 120 min, no changes were verified after the
ingestion of the glass device. This demonstrated that if a
device is de-bonded or broke, there is no risk of F absorption
into the blood stream.
Regarding local side-effects, some authors reported
mucosal irritation, erythema and/or small ulcers in some of
the subjects11,37. On the other hand, a more recent study
reported no adverse effects in the oral tissues during the
study period34; the volunteers did not report discomfort or
local irritation, nor found the device bulky. With respect to
gingival indices in children and adolescents, Andreadis, et
al.7 (2006) showed no significant differences in the
measurements done at days 1, 90 and 180 after the placement
of a glass device, although there was a tendency for increased
plaque retention on the top of the devices.
RETENTION
Although the use of F releasing devices has been proved
to be effective in raising salivary F concentrations at levels
that lead to significant reductions in dental caries prevalence,
besides the absence of toxicological and side-effects,
keeping the device in position has been the major challenge
found by the investigators, regardless of the type of the
device used. The first studies conducted with the copolymer
device showed very low retention rates, even in short-term
trials. Mirth, et al.37 (1982) reported a 65% loss or damage
rate after 35 days of placement of the devices. Similar findings
were obtained in 50-day11 and 6-month trials17,26, which were
conducted in order to improve the retention rates.
In 1998, Billings, et al.9 evaluated new methods for
retaining the copolymer devices intra-orally, which
consisted of devices with different sizes and shapes
combined to different orthodontic-type retainers. After 6
months of evaluation, the retention rate was 85%, of which
100% were still functional. Even better results were obtained
in the study conducted by Marini, et al. 34 (1999), in which a
new holder called CIPI was tested. This holder was made of
a biocompatible elastic alloy designed specifically for
orthodontic patients, consisting of a retentive four-wire cage
provided with a cannula and a clasp. After 12 months, the
retention rate was greater than 98%. The results obtained
from both studies show that it is possible to adequately
protect and retain the devices in the mouth for prolonged
periods of time.
Retention rates for the glass devices were also low in
the first clinical trials, although it was reported as 100% in
the first pilot studies involving 1 and 4 subjects, for the
period of 18 and 7 months, respectively15. In the first large
clinical trial, Toumba and Curzon55 (2005) reported only a
48% retention rate using the original “dome-shaped” devices
in children. According to the authors, the possible reasons
for such a low rate were related to the lower co-operation
found in children in comparison to adult volunteers;
difficulty in moisture control; incomplete establishment of
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children’s occlusion in the mixed dentition stage; and a
deliberate dislodging of the devices by the child volunteers.
Such low retention rates in children prompted the
development of new shapes of glass devices and retention
methods that could lead to an increase in such rates.  A
kidney-shaped glass device with circumferential retentive
grooves was evaluated by Andreadis, et al.7 (2006) for use
in children and adults, as shown in Figure 3. After 6 months
of placement, the retention rates were 93% and 86%,
respectively for children and adults. Such an improvement
in the retention was attributed to the large amount of
composite resin used for the attachment of the devices,
which provided a substantial bulk, which was able to resist
both masticatory and brushing forces. Besides, one factor
that could explain the success obtained in children was that
this new shape device had a shorter height (2.5 mm, against
4 mm for the old shape), which is an important factor when
considering that children’s molars are usually not fully
erupted, so the space available for placement of the device
is critical.
The most recent approach was the development of plastic
brackets to be used with dome shaped glass beads (Figures
4 and 5). The rationale for this new system is that such
brackets would be attached only once, thus facilitating
handling and replacement, besides reducing the bulk of the
resultant attached device. For adults, 85% of the devices
were retained after 6 months of placement, while in children
less than 8 years old  the retention rates were 60% and 0%
after 1 and 6 months, respectively5. Thus, this new system
for placement and replacement of glass devices seem to be
a good alternative for adults, while the kidney shaped type
is a good alternative for children with developing occlusions.
FINAL CONSIDERATIONS
Although there are a substantial number of studies
addressing the effects of slow-release F devices on intra-
oral F levels, as well as its effects on de- and remineralisation
processes, the great majority of these were in vitro and in
situ investigations. One recent meta-analysis10 was
conducted in order to evaluate the clinical effect of slow-
release F devices on caries prevalence, but only one clinical
trial55 fulfilled the criteria adopted. However, as previously
mentioned, the evidence from this study was considered as
not strong because the authors did not analyze the data on
an intention-to-treat basis. Thus, it is evident that further
clinical trials are still needed in order to provide a substantial
body of evidence that the use of such devices constitutes
an effective and viable measure for the control of dental
caries. Future investigators should consider the weaknesses
pointed out by the meta-analysis conducted by Bonner, et
al.10 (2006), which mainly included lack of randomisation
and/or inadequate study design. Besides the use of these
devices in children and other well-known patient groups
that are non-compliant, have poor attendance and are mainly
from low socio-economic groups, it would be instructive to
evaluate their use for the prevention of enamel and root
caries in medically compromised groups, ethnic groups,
patients undergoing orthodontic treatment individuals with
dentine sensitivity and xerostomia/irradiation patients52.
In addition, it is worth highlighting that the use of the
slow-release devices have been shown to have a very
favourable benefit-cost and cost-effectiveness ratios23. In
the clinical trial conducted by Toumba51 (1996), the cost-
effectiveness of the glass device was 0.72, meaning that the
cost for saving one dental surface over a period of two
years was £0.72.
According to Featherstone19 (2006), there is a major anti-
caries effect for high caries individuals if a “therapeutic level”
of fluoride at a background level of around 0.1 ppm F in
saliva can be achieved day and night. Any additional fluoride
delivery, such as twice daily brushing with a fluoride
toothpaste, would be a bonus. A sustained-release device
that functions to provide the same protection as the glass
device referred to above should be targeted only in a more
acceptable form to the patients. Such a device would
overcome compliance problems and could be targeted with
success to high caries-risk individuals. It may not eliminate
all caries, but would lead to dramatic reductions, and in
combination with anti-bacterial treatments could indeed
eliminate caries in these individuals.
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